GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » Price-to-Tangible-Book

GlaxoSmithKline Pharmaceuticals (BOM:500660) Price-to-Tangible-Book : 23.89 (As of Jun. 07, 2024)


View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-06-07), GlaxoSmithKline Pharmaceuticals's share price is ₹2473.25. GlaxoSmithKline Pharmaceuticals's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ₹103.54. Hence, GlaxoSmithKline Pharmaceuticals's Price to Tangible Book Ratio of today is 23.89.

The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

BOM:500660' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 8.9   Med: 11.85   Max: 23.95
Current: 23.89

During the past 13 years, GlaxoSmithKline Pharmaceuticals's highest Price to Tangible Book Ratio was 23.95. The lowest was 8.90. And the median was 11.85.

BOM:500660's Price-to-Tangible-Book is ranked worse than
96.5% of 858 companies
in the Drug Manufacturers industry
Industry Median: 2.255 vs BOM:500660: 23.89

A closely related ratio is called PB Ratio. As of today, GlaxoSmithKline Pharmaceuticals's share price is ₹2473.25. GlaxoSmithKline Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2024 was ₹104.93. Hence, GlaxoSmithKline Pharmaceuticals's P/B Ratio of today is 23.57.


GlaxoSmithKline Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Price-to-Tangible-Book Chart

GlaxoSmithKline Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.91 17.01 10.72 13.14 18.77

GlaxoSmithKline Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.14 - 17.32 - 18.77

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Price-to-Tangible-Book falls into.



GlaxoSmithKline Pharmaceuticals Price-to-Tangible-Book Calculation

GlaxoSmithKline Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=2473.25/103.543
=23.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


GlaxoSmithKline Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines